Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
Marc E Buyse, Pierre Guillame Thirion, Robert W. Carlson et al. · The Lancet · 2000
Cited by 427 works. doi:10.1016/s0140-6736(00)02528-9
Authors
- Marc E Buyse
- Pierre Guillame Thirion
- Robert W. Carlson
- Tomasz Burzykowski
- Geert Molenberghs
- Pascal Piedbois
References
- A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
- Analysis of survival by tumor response.
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
- Analysis of survival by tumor response.
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
- Statistical validation of intermediate endpoints for chronic diseases
- Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.
- Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
- ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER